Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.39 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30994809 | 1.00 | CHRNB2 (0.39) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| SCHEMBL30598789 | 0.98 | CA2 (0.38) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| SCHEMBL1083049 | 0.98 | CA2 (0.38) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| Hydrochloric Acid SCHEMBL27687817 | 0.95 | CA2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| SCHEMBL2907407 | 0.95 | CA2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| Water SCHEMBL23356455 | 0.95 | CA2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| Hydrochloric Acid SCHEMBL28060532 | 0.95 | CA2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| Propionic Acid SCHEMBL28044756 | 0.86 | FFAR3 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6 | |
| SCHEMBL29052233 | 0.85 | ALDH1A1 (0.37) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL31591139 | 0.85 | ALDH1A1 (0.37) | ALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4583926-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | claimed |
| WO-2024052550-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | claimed |
| EP-4308551-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | Bayer Aktiengesellschaft (DE) | 2024-01-24 | — | — | EP | claimed |
| WO-2022194777-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-22 | — | — | WO | claimed |
| CN-122094950-A | Ligand compound with quinoline structure, and radioactive or non-radioactive marker and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122055172-A | Chimeric radiopharmaceuticals targeting the proton-sensitive receptor GPR4 | 安菲利克斯股份公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4583926-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| CN-120129679-A | VHH antibody DOTA conjugates | 雅博得乐医疗公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-119192214-B | Targeted binding fibroblast activation protein multimeric compound and application thereof | 杭州景嘉航生物医药科技有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119192214-A | Targeted binding fibroblast activation protein multimeric compound and application thereof | 杭州景嘉航生物医药科技有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-118955616-A | Targeted binding fibroblast activation protein compound and application thereof | 杭州景嘉航生物医药科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118619941-A | Nitrogen-containing heterocyclic compound, and preparation method and application thereof | 晶核生物医药科技(南京)有限公司 | 2024-09-10 | — | — | CN | disclosed |
| WO-2024052550-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4308551-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | Bayer Aktiengesellschaft (DE) | 2024-01-24 | — | — | EP | disclosed |
| CN-111886226-B | Compounds, anti-inflammatory agents containing the same, and cyclooxygenase-2 inhibitors | 张用敏 | 2023-08-15 | — | — | CN | disclosed |
| WO-2022194777-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-22 | — | — | WO | disclosed |
| WO-2019182393-A1 | COMPOUND HAVING NOVEL STRUCTURE, ANTI-INFLAMMATORY AGENT COMPRISING SAME, AND MATRIX METALLOPROTEASE-9 INHIBITOR COMPRISING SAME | 경북대학교 산학협력단 | 2019-09-26 | — | — | WO | disclosed |
| WO-2019182395-A1 | COMPOUND HAVING NOVEL STRUCTURE, ANTI-INFLAMMATORY AGENT COMPRISING SAME, AND CYCLOOXYGENASE-2 INHIBITOR COMPRISING SAME | 장용민 | 2019-09-26 | — | — | WO | disclosed |